Receptors, signaling cascades, and biological pathways.
Every peptide has a specific shape that fits a corresponding receptor — like a key fitting into a lock. When a peptide binds to its receptor on a cell surface, it activates a signaling cascade inside the cell. This specificity is what makes peptides so targeted: BPC-157 binds to receptors involved in tissue repair, while Selank targets receptors in the brain that regulate anxiety.
Each peptide has a unique 3D shape that fits specific receptors — this lock-and-key mechanism is why peptides can target precise biological functions.
When a peptide docks with its receptor, it doesn't just flip one switch. It triggers a cascade — a chain reaction of molecular events inside the cell. This might activate genes, produce new proteins, or release other signaling molecules. A single peptide binding event can amplify into thousands of molecular responses, which is why even small doses can produce significant effects.
A single peptide binding event triggers thousands of downstream molecular responses — this amplification effect is why peptides are potent even in tiny amounts.
Not all peptides reach their targets equally. Bioavailability refers to how much of a peptide actually makes it into your bloodstream and to the target tissue. Oral peptides face destruction by stomach acid, which is why most therapeutic peptides are administered via subcutaneous injection, nasal spray, or topical application. Half-life — the time it takes for half the peptide to be cleared — determines dosing frequency.
Administration method matters: subcutaneous injection offers the best bioavailability for most peptides, while oral forms face significant degradation.